Liam Ratcliffe
Affiliations
- Director at Arvinas Inc. (ARVN), 2020-06-05
- Director at Passage Bio Inc. (PASG), 2020-03-13
- Director at Unum Therapeutics Inc. (UMRX), 2019-06-18
- Director at Aptinyx Inc. (APTX), 2019-04-02
- Director at Edge Therapeutics Inc. (EDGE), 2019-03-18
- Large Shareholder at Iterum Therapeutics Plc (ITRM), 2018-05-31
- Large Shareholder, Director at Deciphera Pharmaceuticals Inc. (DCPH), 2018-05-21
- Large Shareholder at Irhythm Technologies Inc. (IRTC), 2016-10-25
- Large Shareholder at Mei Pharma Inc. (MEIP), 2015-03-26
- Large Shareholder at Versartis Inc. (VSAR), 2014-12-22
- Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-11-18
- Large Shareholder at Chimerix Inc (CMRX), 2014-03-20
- Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
- Other at Oxford Immunotec Global Plc (OXFD), 2013-12-03
- Other at Relypsa Inc (RLYP), 2013-11-21
- Director at Array Biopharma Inc (ARRY), 2013-10-25
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| PASG | $18.00 | 2,800 | Director | 2,800 | 2020-03-03 | Filing | |
| PASG | $18.00 | 550,000 | Director | 2,616,630 | 2020-03-03 | Filing | |
| PASG | $18.00 | 2,800 | Director | 2,800 | 2020-03-03 | Filing | |
| ARVN | $22.00 | 680,000 | Director | 680,000 | 2019-11-12 | Filing | |
| ARVN | $16.00 | 375,000 | Director | 375,000 | 2018-10-01 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| ARRY | $5.99 | 863,521 | Director | 0 | 2013-09-27 | Filing | |
| ARRY | $6.02 | 262,207 | Director | 863,521 | 2013-09-26 | Filing | |
| ARRY | $6.14 | 319,033 | Director | 1,125,728 | 2013-09-16 | Filing | |
| ARRY | $6.01 | 546,660 | Director | 1,444,761 | 2013-09-13 | Filing | |
| ARRY | $6.10 | 807,479 | Director | 1,991,421 | 2013-09-12 | Filing |